Royalty Pharma EPS - Earnings per Share 2019-2024 | RPRX

Royalty Pharma earnings per share (EPS) for the twelve months ending September 30, 2024 was $2.56, a 573.68% increase year-over-year.

  • Royalty Pharma EPS for the quarter ending September 30, 2024 was $1.21, a 656.25% increase year-over-year.
  • Royalty Pharma 2023 annual EPS was $2.53, a 2430% increase from 2022.
  • Royalty Pharma 2022 annual EPS was $0.1, a 93.29% decline from 2021.
  • Royalty Pharma 2021 annual EPS was $1.49, a 12.88% increase from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Royalty Pharma EPS - Earnings per Share 2019-2024 | RPRX

  • Royalty Pharma EPS for the quarter ending September 30, 2024 was $1.21, a 656.25% increase year-over-year.
  • Royalty Pharma 2023 annual EPS was $2.53, a 2430% increase from 2022.
  • Royalty Pharma 2022 annual EPS was $0.1, a 93.29% decline from 2021.
  • Royalty Pharma 2021 annual EPS was $1.49, a 12.88% increase from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.